] prion (10, 11). Amyloid is a filamentous β-sheet-rich protein polymer, and the yeast prion amyloids have a folded, in-register, parallel β-sheet architecture (12-15). This architecture provides a mechanism by which proteins can template their conformation, much as DNA templates its sequence, and explains the rather stable propagation of many different prion variants (called "prion strains" in mammals) based on different conformations of a single prion protein (16, 17).
M ost organisms devote a substantial part of their genome to opposing viral propagation and takeover of cellular processes. Humoral and cellular immune systems, RNAi-based systems, innate immunity, physical barriers to penetration, interferons, the SKI-based systems, and many others have been selected to keep virus propagation in check. Infectious proteins, prions, have not been studied as widely, but already antiprion systems have been recognized.
The translation termination subunit, Sup35p, can form an infectious protein, [PSI + ] by conversion to a self-propagating amyloid form (1) (2) (3) (4) (5) (6) . Similarly, Ure2p, a mediator of nitrogen catabolite repression, can form the amyloid-based [URE3] prion (1, (7) (8) (9) and Rnq1p forms the [PIN + ] prion (10, 11) . Amyloid is a filamentous β-sheet-rich protein polymer, and the yeast prion amyloids have a folded, in-register, parallel β-sheet architecture (12) (13) (14) (15) . This architecture provides a mechanism by which proteins can template their conformation, much as DNA templates its sequence, and explains the rather stable propagation of many different prion variants (called "prion strains" in mammals) based on different conformations of a single prion protein (16, 17 ).
Chernoff's seminal discovery that Hsp104 overproduction or deficiency could cure the [PSI + ] prion (18, 19) led to detailed dissection of the mechanisms of these effects, and discovery of the involvement of many other chaperones and cochaperones. Hsp104 (20) is a disaggregating chaperone, which acts with Hsp70s and Hsp40s to solubilize proteins (21) . Monomers are removed from the aggregate and fed through the central cavity of the Hsp104 hexamer, thereby denaturing them and allowing them a chance to properly refold (22) (23) (24) . Millimolar guanidine HCl is a surprisingly specific inhibitor of Hsp104 (25) (26) (27) (28) (29) , and has been used to show that the effect of Hsp104 inactivation on prion propagation is to block the generation of new seeds (also called propagons) (30) (31) (32) ). Hsp104's prion-propagating activity, like its general disaggregating activity, also involves Hsp70s and nucleotide-exchange factors, as well as Hsp40s. Hsp70s, the cytoplasmic Ssas of Saccharomyces cerevisiae, are necessary for stable prion propagation (33) (34) (35) (36) (37) , and can antagonize the curing of [PSI + ] by overproduction of Hsp104 (38) , an effect requiring Sgt2 (39) . The Hsp40 role in prion propagation includes considerable prion-specificity of the various Hsp40s (40, 41) . The need for collaboration between Hsp104, Hsp70s, Hsp40s, and nucleotide-exchange factors in prion propagation was shown by the ability of Escherichia coli homologs, ClpB, DnaK, and GrpE, to substitute for their yeast relatives only if they could interact with their E. coli partners (42) . (47) . Indeed, inhibition of Hsp90s with radicicol blocks the curing activity of overproduced Hsp104 (47) . These results suggest a role of Hsp90s in the Hsp104 prion curing process.
The mechanism of Hsp104 overproduction curing of [PSI + ] remains controversial. One proposal is that overproduced Hsp104 binds to a special site in the middle (M) domain of Sup35p (49) and so prevents Hsp70s from having access to the filaments, which access is believed necessary for the Hsp104-Hsp70-Hsp40 machine to extract a monomer from the filament and thereby cleave it (37 ] variants arising spontaneously in the absence of this Hsp104 overproduction curing activity are cured when that activity is restored at normal levels. This activity is thus an antiprion system, largely protecting the cells from prion formation by this protein.
Another model proposes that overproduction curing represents removal of Sup35p monomers from the ends of filaments, thereby eventually solubilizing the filaments (50) . A third group posits assymetric segregation of prion seeds that have been collected by the overproduced Hsp104, with some cells emerging from the division with no seeds (51) . There is substantial evidence for each of these models.
Although extensive studies have probed the mechanism of Hsp104 overproduction curing, less is known about its biological role. During the usual heat-shock regime, little curing of [ (63, 64) . Btn2p acts by collecting Ure2p amyloid aggregates to one place in the cell so that following division, one of the daughter cells is cured (63, 64) . Btn2p and Cur1p are each also able to collect nonprion protein aggregates (63, 65, 66) T160M strain (Fig. S1A) . We restored the WT Hsp104 (with the curing activity, but at normal levels) by cytoduction (cytoplasmic transfer) (Methods) of these prions into an isogenic WT host, or into another hsp104 T160M strain as a control ( Fig. S1B ). Statistical tests were carried out as described in Methods.
hspB5, hspB7, hspB20; hspA3, hspA4, hspA5, hspA6, hspA7, hspA9, hspA15, hspA19, hspA20). We also found a few such variants among those generated in the WT background (wtB19; wtA3, wtA13). Two of these were very unstable in the WT parent and were apparently stabilized by the hsp104 T160M mutation. Most variants generated by Sup35NM overexpression in the WT background cytoduced well to both WT and hsp104 T160M recipients (28 of 40, green variants). The fraction of orange variants among those generated in the hsp104 T160M background was higher than in variants generated in the WT background [12 of 40 in hsp104 T160M vs. 3 of 40 isolated in the WT host (P < 10 −4 )]. We also found variants that cytoduced to both recipients poorly, but with near equal efficiency [white variants (shown as white in the tables)]. Surprisingly, we found several variants generated in the hsp104 T160M background that cytoduced significantly better to WT recipients than to hsp104 T160M ones (variants hspB1, hspB3, hspB10, hspB13 ] measures translational read-through of the ade2-1 mutation that results from the deficiency of translation termination factor Sup35p, produced by its being largely tied up in the amyloid filaments. A phenotypic masking effect would be a direct effect of the hsp104 T160M mutation on translational read-through. It has been previously shown that hsp104 T160M has no such [PSI+]-independent effect (43) .
We also did back-cytoductions from Ade + cytoductants (Table 3 ). The orange variant converted to a green variant when transferred to a WT. This result is consistent with the "cloud of variants" model according to which a [PSI + ] cell contains a mixture of prion variants, with one or another becoming stochastically dominant (68) (69) (70) To make sure that the T160M mutation in HSP104 and not some other accompanying mutation underlies the inability of our hsp104 T160M recipient strain to cure a significant fraction of spontaneously appearing [PSI + ] variants, we used the CRISPR-Cas technique to restore the WT allele of HSP104 in this particular strain, and performed the cytoductions as previously. The results confirm the primary role of the T160M mutation in making Hsp104 unable to cure some [PSI + ] variants because transmission of orange prion variants into both WT-CRISPR strains was significantly less efficient compared with cytoduction into hsp104 T160M recipients, whereas green variants were well propagated by the CRISPR-restored hosts (Table 4) .
Strong/Weak, Seed Number, and Hsp104 Hypersensitivity. We do not find a correlation between the strong/weak or stable/unstable nature of a variant and its ability/inability to propagate in the presence of normal levels of WT Hsp104. For example, hspA4 is a strong very stable [PSI + ] (Fig. 1A) , but is highly sensitive to curing . by normal levels of Hsp104 (Table 2) . Similarly, the weak very unstable variant hspA5 (Fig. 1) shows a similar sensitivity to normal levels of WT Hsp104 (Table 2) . Furthermore, we did not observe any correlation between seeds/cell and the green vs. orange property of variants (Fig. 1C) .
Mutability of Hsp104 Hypersensitive [PSI +
]. We noted the gradual change of orange variants toward green on repeated passage in an hsp104 T160M host on -Ade medium (Table S1 ). The difference in cytoduction efficiencies of these variants into WT and hsp104 T160M recipients gradually decreased with growth. In contrast, we did not observe such changes in the case of green variants. This finding suggests that initially orange variants include a small minority of green variants (the prion cloud), and that the green variants have an advantage over orange variants, even in an hsp104 T160M host. Note that even the strong, stable orange variant hspA4 gradually becomes green on repeated culturing (Table S1 ).
Proteins Associated with Hsp104 and Hsp104(T160M). We used coimmunoprecipitation (co-IP) to compare the binding partners of WT Hsp104 and Hsp104
T160M
. The binding of most interactors with the mutant Hsp104 was approximately as effective as with WT Hsp104 (Table S2 ). The only protein that consistently co-IP with Hsp104 T160M less effectively was Ura2 (aspartate transcarbamylase), a known Hsp90 client (71) (Table  S2) , thus leaving the possibility that the decrease in Ura2 binding is a result of somewhat weaker interaction of Cpr6 with Hsp104 T160M . As for three other Hsp90 cochaperones, the T160M mutation slightly impairs interaction with Sti1 (Table S2 ). Hsp104 is a hexamer and, as expected, we detected the binding of Hsp104 to itself that was not changed in the mutant strain (Table S2) . , respectively) ( Table 5 and Fig. S2 Chaperone Levels in HSP104 vs. hsp104 T160M . Potentially, the difference in curing ability of WT and hsp104 T160M recipient strains could be a result of differences in protein levels of Hsp104 or other chaperones/cochaperones and related proteins between these strains. Western blot analysis (Fig. 3) showed that the levels of Hsp104, Ssa1-4, Sti1, Cpr7, and Ydj1 were not changed in the hsp104 T160M mutant compared with the isogenic WT, whereas the level of Sis1 was 1.4 times increased, and the level of Sse1/2 was 1.3 times decreased. It is known that having two copies of the SIS1 gene in the cell does not influence [ (74) . We also find the levels of Sup35 and Hsp104 are approximately the same in the mutant as in the CRISPR-corrected WT (Fig. 3) . (38) . Consistent with these findings, we also observed that the cytoduction efficiency of some variants (e.g., orange hspB5, hspB7, hspA9; white wtA4, wtA10, hspA2) into ssa1Δ was impaired compared with that into a WT recipient. Sgt2p is known to help overproduced Ssa1p antagonize Hsp104 overproduction curing of [PSI + ], indicating a 
pro-[PSI

+
] activity for Sgt2 (39) . We found that most orange variants (e.g., wtA3, hspA4, hspA5, hspA15, hspA19) cytoduced into sgt2Δ nearly as efficiently as into the hsp104 T160M recipient, and generally better than into the WT. Several variants (e.g., white wtA10 and hspA14; orange hspA3, hspA4, hspA5, hspA6 and hspA7) cytoduced into sti1Δ significantly better than into the WT recipient. These results suggest that Sgt2 and Sti1 are helping, whereas Ssa1 is counteracting the curing of some [PSI + ] variants by the normal level of Hsp104. Most orange variants (hspB5, wtA3, wtA7, hspA3, hspA4, hspA5, hspA6, hspA7, hspA9, hspA17, hspA19) cytoduced into sis1 Δ338-352 recipients nearly as efficiently as into hsp104 T160M (Table 6 ), consistent with this deletion's known total abrogation of Hsp104 overproduction curing (72 ] by the normal level of Hsp104 because both green and orange variants that we've tested cytoduced with similar efficiency into 74-D694 WT and 74-D694 btn2Δ cur1Δ recipients (Table S3) . Deletion of HSP42 does not substantially affect the propagation of any variants tested (Table 7) , consistent with our earlier findings (64) .
Yeast cells need at least one of the highly similar isoforms of Hsp90 (HSP82 and HSC82) to be viable (76), so we used the strains in which the hsp82Δ hsc82Δ double deletion was compensated by either a WT or mutant copy of HSP82 expressed under the control of its native promoter from a centromere plasmid. We used either hsp82ΔMEEVD or hsp82
W585T mutants in our experiments. The C-terminal MEEVD motif of Hsp82 is critical for interaction with tetratricopeptide repeat domain-containing cochaperones such as Cpr7, Sti1, Cpr6, and Cns1, so its deletion disturbs these interactions (45) . Hsp82
W585T protein is defective in client binding and chaperone activity (77) . Mutant Hsp82 results in increased cytoduction efficiency of orange [PSI + ] variants, suggesting that Hsp82 is involved in the Hsp104 normal-level curing (Table 7) , as it has previously been shown to be involved in Hsp104 overexpression curing of [PSI + ] (47).
Discussion
The lethal potential of yeast prion infections (54) suggested that cellular defense mechanisms should have evolved. Because overproduction of Hsp104 cures [PSI + ] (18, 19) , and the mechanism of this curing appears to be distinct from that of its prion propagationpromoting activity (43) (Table 7) . Furthermore, the sis1Δ338-352 mutation that eliminates Hsp104 overproduction curing (72) ] variants on overproduction of Hsp104. Although our work does not specifically address the mechanism, the fact that [PSI + hhs] curing occurs without Hsp104 overproduction suggests that overproduction is not an inherent component of the mechanism. The hsp104 T160M mutation was originally isolated by its suppressing the [PSI + ]-destabilizing dominant SSA1-21 mutation, and sti1, hsp90, and sis1 mutations had a similar effect (43, 47, 72) . This earlier work also suggested that Hsp104 is part of an antiprion system that does not require overproduction to be active. Likewise, our [PSI *The data for the cytoductions from green and orange donors to these WT and hsp104 T160M recipients are the same as in Table 2 . The statistics relate the CRISPR-corrected recipient strains wt-CR11 and wt-CR12 to the mutant parent, hsp104 T160M Ura − (strain AG730). (85) . This is thus another example of a chaperone shaping the spectrum of prion variants.
Although there are now many means of curing yeast prions, few have been shown to be naturally acting curing mechanisms, in contrast to artificial imbalance of components involved in or affecting the prion propagation process. These antiprion systems, like DNA repair systems, are not completely effective, but certainly lower the burden of prions on the host, and shape the array of prion variants that will succeed in arising. Table S4 and growth media are as described by Sherman (86) . Yeast were grown at 30°C. Knockout mutations (87) were transferred by PCR amplification, transformation of the target strain, and confirmation, using PCR, of the absence of the normal allele and the presence, in the correct location, of the mutant allele. Cytoduction. Donors and recipients were isogenic (to 779-6A in most cases) ( Table S4 ). ] variants also carried the LEU2 plasmid pHK006 (bearing P Gal1 -SUP35NM which is not expressed on glucose-containing media) ( Table S5 ). The recipient carried the HIS3 plasmid pRS313 to allow selection against donors and distinction of diploids and recipients. Recipients were made ρ 0 by growth on media containing 25 μg/mL ethidium bromide, and transfer of mitochondrial DNA, as assayed by growth on glycerol, was used as an indicator that cytoplasm had been transferred from donor cells. Donor and recipients were mixed in water with a modest excess of donor cells, and spotted on a YPAD plate. After 6-to 8-h incubation at 30°C, the mixture was streaked for single colonies on media selecting against the donor. Colonies were replica-plated to YPG, media selective for diploids (two types: one was -Leu and the other was -Trp) and -Ade. Clones growing on YPG but not on the media selective for ] variants hypersensitive to Hsp104. Some probabilities shown as, for example, "(81%).05," where 0.05 is the P value. *The data for cytoductions from green and orange donors to WT and hsp104 T160M recipients are the same as in Table 2 . † P < 10 The back-cytoduction recipients carried the TRP1 vector pRS314 as a marker and, like the forward-cytoduction recipients, were ρ 0 .
Statistics. We used the binomial distribution to assess the significance of differences of transmission frequency between strains or of frequency differences of a yes/no type between groups. For example, whether an orange variant's transmission to a WT recipient was significantly different from transmission to an isogenic hsp104 T160M recipient usually used this method. The mean transmission frequency (p), of the total population (adding cytoductants to both mutant and WT), the total number of cytoductants (N), and the binomial dis- ] prion seeds contained by the cell which gave rise to the colony. For each strain, at least 10 individual colonies were tested (88) .
Western Blot Analysis. Yeast were grown overnight at 30°C in YPAD, washed with water, and suspended in Disruption buffer [25 mM Tris·Cl pH 7.5, 150 mM NaCl, 1 mM DTT, 10 mM MgCl 2 , 1.2 mg ATP/mL, 1× Halt Protease Inhibitor Mixture (Thermo), one tablet Complete Mini Protease Inhibitor EDTA free (Roche)/8 mL, and 10 mM Prefabloc]. The cell suspension was placed, with glass beads, in screw-cap 2-mL tubes, and disrupted using a Bead Beater homogenizer (3 min, 4°C). Protein concentrations were determined using the BCA assay and equalized between the samples using Disruption buffer. The samples were analyzed on a polyacrylamide gel and transferred to a PVDF membrane. The primary and the secondary antibodies used to perform the membrane staining are listed in Table S6 .
Proteins Co-IP with Hsp104 and Hsp104
T160M
. Cells of strain AG686 (WT) and AG687 (hsp104T160M) were grown and extracts made as described above for Western blots. Forty microliters of extract was mixed with 1 μL of antiHsp104 antibody and 460 μL of Disruption buffer (see Western blot method described above) in a 2-mL screw-cap tube and incubated overnight at 4°C with slow mixing. Magnetic beads from the Pierce Classic Magnetic IP/co-IP kit were washed two times with 1 mL of Washing buffer (Disruption buffer without the protease inhibitors or detergents), the extract-antibody mixture was added to these beads, and the suspension was incubated for 1 h at room temperature with rotation. Beads were then washed three times with the Washing buffer, and proteins were eluted with 8 M urea in 100 mM Tris·Cl pH 7.5. Protein components were then subjected to proteolysis, on-column postdigestion reductive di-methylation, and quantitative proteomics essentially using approaches described by others (89) (90) (91) , with details provided in SI Methods. T160M recipients are the same as in Table 6 . † P < 10 −5 . Comparisons are shown between the hsp82Δ hsc82Δ strain complemented by WT HSP82 and mutant hsp82 plasmids.
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